Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Astrazeneca Plc ADR
(NQ:
AZN
)
78.59
+0.47 (+0.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Astrazeneca Plc ADR
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
55
56
Next >
7 Large-Cap Stocks With Sustained Dividend Growth Potential
July 05, 2022
While there is a tendency to pursue growth stocks for healthier portfolio returns, large-cap stocks have been silent performers.
Via
InvestorPlace
U.S. Stock Futures Drop Following Another Week Of Losses
July 05, 2022
Pre-open movers U.S. stock futures traded lower in early pre-market trade on Tuesday after Wall Street recorded losses for another week and closed one of the worst halves in decades on Thursday....
Via
Benzinga
AstraZeneca Shares Data at EASL and ESMO World GI for IMFINZI® (durvalumab) Combinations in Patients With Liver and Biliary Tract Cancers
July 01, 2022
From
AstraZeneca
Via
Business Wire
The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact
July 01, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Short Volatility Alert: AstraZeneca PLC
June 22, 2022
On Tuesday, shares of AstraZeneca PLC (NASDAQ: AZN) experienced volatile short activity. After the activity, the stock price went up 2.85% to $62.83. The overall sentiment...
Via
Benzinga
FDA Expert Panel Favors COVID-19 Boosters Targeting Omicron BA.4, BA.5 Subvariants
July 01, 2022
Via
Benzinga
Benzinga Before The Bell: Kohl's Deal Talks Cancellation, Tesla's Racial Discrimination Lawsuit, Nio's Strong June Deliveries And Other Top Financial Stories Friday, July 1
July 01, 2022
CNBC Why Kohl’s Shares Are Plunging Today
Via
Benzinga
Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca's COVID-19 Vaccine
July 01, 2022
Via
Benzinga
The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial
June 30, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
AstraZeneca Says Imfinzi/Chemo Combo Shows Promising Action In Late-Stage Lung Cancer Study
June 30, 2022
Via
Benzinga
IMFINZI® (durvalumab) Plus Chemotherapy Significantly Improved Pathologic Complete Response in AEGEAN Phase III Trial in Resectable Non-Small Cell Lung Cancer
June 30, 2022
From
AstraZeneca Pharmaceuticals
Via
Business Wire
7 Beaten-Down S&P 500 Stocks to Buy Before They Rebound
June 30, 2022
With the market becoming more convinced that a "soft landing" is in the cards, there are many good, beaten-down S&P 500 stocks to buy.
Via
InvestorPlace
Akebia Therapeutics (AKBA) Stock Soars 18% Despite Lack of News
June 29, 2022
AKBA stock is up big, but the lack of news is concerning considering that Akebia Therapeutics already faces a regulatory setback.
Via
InvestorPlace
AstraZeneca Whale Trades For June 29
June 29, 2022
Someone with a lot of money to spend has taken a bearish stance on AstraZeneca (NASDAQ:AZN). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
June 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
EMA's Advisory Committee Backs Approval For AstraZeneca's Targeted Breast Cancer Therapies
June 27, 2022
Via
Benzinga
Week In Review: InvoX, A Sino Biopharma Company, To Pay $161 Million To Acquire F-Star
June 26, 2022
InvoX Pharma, a Sino Biopharma subsidiary, will pay $161 million to acquire F-Star, a clinical stage company developing bispecific drugs for immunotherapies. Meanwhile, Reistone Biopharma completed a...
Via
Talk Markets
What Are Whales Doing With AstraZeneca
June 24, 2022
Someone with a lot of money to spend has taken a bearish stance on AstraZeneca (NASDAQ:AZN). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
AstraZeneca's ALXN1840 Shows Promising Action Against Copper Metabolism Disorder
June 23, 2022
Via
Benzinga
ALXN1840 Shows Rapid and Sustained Improvement in Copper Mobilization From Tissues, Potentially Closing Treatment Gaps for Wilson Disease Community
June 23, 2022
From
Alexion
Via
Business Wire
Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money
June 22, 2022
With an economic hurricane on the horizon, investors are searching for alternative investment paths and profitable places to invest in.
Via
InvestorPlace
7 Blue-Chip Stocks to Buy and Hold for the Long-Haul
June 22, 2022
Blue-chip stocks that are worth accumulating in the market correction. Undervalued blue-chip stocks with robust cash flows.
Via
InvestorPlace
The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial
June 21, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
AstraZeneca - Ionis Eplontersen Achieves Positive Data In Rare Disease Trial
June 21, 2022
Via
Benzinga
PROpel Phase III Trial Positive Results of LYNPARZA® (olaparib) Plus Abiraterone in 1st-line Metastatic Castration-resistant Prostate Cancer Published in New England Journal of Medicine Evidence
June 21, 2022
From
AstraZeneca
Via
Business Wire
Eplontersen Met Co-Primary and Secondary Endpoints in Interim Analysis of the NEURO-TTRansform Phase III Trial for Hereditary Transthyretin-Mediated Amyloid Polyneuropathy (ATTRv-PN)
June 21, 2022
From
AstraZeneca
Via
Business Wire
Dow Jones Erased Gains Late in the Day, as Investors Continued to Consider Fears About Sluggish Economic Is Growth.
June 18, 2022
For the third week in a row, the S&P 500 lost the most ground of any of the three major
Via
Best Stocks
Topics
Stocks
Exposures
US Equities
Why Mereo BioPharma Shares Are Jumping Today
June 17, 2022
Via
Benzinga
Dow Jones Today: Investors Flee The Markets On The Belief That The Federal Reserve Would Choose For The First Three-quarter Point Hike
June 14, 2022
There have been exceptions to the rule when interest rates climb quickly. Federal Reserve officials will meet on Tuesday to
Via
Best Stocks
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Teladoc Can’t Rely On Hype To Attract Investors
June 13, 2022
Investors should think twice before buying TDOC stock, considering the negative impact of the stay-at-home phase ending.
Via
InvestorPlace
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
55
56
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.